1887

Journal of General Virology header logo

Volume 86, Issue 4

The Plowright vaccine strain of has attenuating mutations in most genes Free

Abstract

The currently used vaccine strain of was derived by serial passage of the highly virulent Kabete ‘O’ strain (KO). A full-length cDNA copy of the KO strain was made from which a virus identical in pathogenicity to the wild-type virus was rescued. A series of chimeric viruses was prepared in which the coding sequences for the N, P, F, H or L proteins were replaced with the corresponding sequences from the vaccine strain. The KO-based virus with the vaccine strain H gene and that with the carboxy-terminal half of the L gene replaced with the corresponding sequence from the vaccine strain retained all or almost all of the virulence of the original KO virus. Animals infected with the KO-based virus containing the vaccine strain N, P or F gene, or the amino-terminal half of the L gene, developed high and prolonged pyrexia and leukopenia, but with reduced or absent lesions and other clinical signs; although partially attenuated, none was nearly as attenuated as the vaccine strain itself. These data indicate that the high attenuation and stability of the current vaccine are due to the accumulation of a number of separate mutations, none of which is itself so sufficiently debilitating that there is strong selective pressure in favour of the revertant.

  • Received:
  • Accepted:
  • Published Online:
SGM
Loading

Article metrics loading...

/content/journal/jgv/10.1099/vir.0.80751-0
2005-04-01
2024-04-20
Loading full text...

Full text loading...

/deliver/fulltext/jgv/86/4/vir861093.html?itemId=/content/journal/jgv/10.1099/vir.0.80751-0&mimeType=html&fmt=ahah

References

  1. Anderson J., Barrett T., Scott G. R. 1996 FAO Animal Health Manual – Manual on the Diagnosis of Rinderpest , 2nd edn. Rome: Food and Agriculture Organisation of the United Nations;
     [Google Scholar]
  2. Bailly J. E., McAuliffe J. M., Durbin A. P., Elkins W. R., Collins P. L., Murphy B. R. 2000; A recombinant human parainfluenza virus type 3 (PIV3) in which the nucleocapsid N protein has been replaced by that of bovine PIV3 is attenuated in primates. J Virol 74:3188–3195 [CrossRef]
     [Google Scholar]
  3. Banyard A. C., Baron M. D., Barrett T. 2005; A role for virus promoters in determining the pathogenesis of Rinderpest virus in cattle. J Gen Virol 86:1083–1092 [CrossRef]
     [Google Scholar]
  4. Baron M. D., Barrett T. 1995; Sequencing and analysis of the nucleocapsid (N) and polymerase (L) genes and the terminal extragenic domains of the vaccine strain of rinderpest virus. J Gen Virol 76:593–602 [CrossRef]
     [Google Scholar]
  5. Baron M. D., Barrett T. 1997; Rescue of rinderpest virus from cloned cDNA. J Virol 71:1265–1271
     [Google Scholar]
  6. Baron M. D., Barrett T. 2000; Rinderpest viruses lacking the C and V proteins show specific defects in growth and transcription of viral RNAs. J Virol 74:2603–2611 [CrossRef]
     [Google Scholar]
  7. Baron M. D., Kamata Y., Barras V., Goatley L., Barrett T. 1996; The genome sequence of the virulent Kabete ‘O’ strain of rinderpest virus: comparison with the derived vaccine. J Gen Virol 77:3041–3046 [CrossRef]
     [Google Scholar]
  8. Britton P., Green P., Kottier S., Mawditt K. L., Penzes P., Cavanagh D., Skinner M. A. 1996; Expression of bacteriophage T7 RNA polymerase in avian and mammalian cells by a recombinant fowlpox virus. J Gen Virol 77:963–967 [CrossRef]
     [Google Scholar]
  9. Bukreyev A., Whitehead S. S., Bukreyeva N., Murphy B. R., Collins P. L. 1999; Interferon gamma expressed by a recombinant respiratory syncytial virus attenuates virus replication in mice without compromising immunogenicity. Proc Natl Acad Sci U S A 96:2367–2372 [CrossRef]
     [Google Scholar]
  10. Das S. C., Baron M. D., Barrett T. 2000a; Recovery and characterization of a chimeric rinderpest virus with the glycoproteins of peste-des-petits-ruminants virus: homologous F and H proteins are required for virus viability. J Virol 74:9039–9047 [CrossRef]
     [Google Scholar]
  11. Das S. C., Baron M. D., Skinner M. A., Barrett T. 2000b; Improved technique for transient expression and negative strand virus rescue using fowlpox T7 recombinant virus in mammalian cells. J Virol Methods 89:119–127 [CrossRef]
     [Google Scholar]
  12. Escoffier C., Manié S., Vincent S., Muller C. P., Billeter M. A., Gerlier D. 1999; Nonstructural C protein is required for efficient measles virus replication in human peripheral blood cells. J Virol 73:1695–1698
     [Google Scholar]
  13. FAO 2003; Rinderpest on the ropes. In Agriculture 21, Magazine of the Food and Agriculture Organization
    [Google Scholar]
  14. Flanagan E. B., Zamparo J. M., Ball L. A., Rodriguez L. L., Wertz G. W. 2001; Rearrangement of the genes of vesicular stomatitis virus eliminates clinical disease in the natural host: new strategy for vaccine development. J Virol 75:6107–6114 [CrossRef]
     [Google Scholar]
  15. Forsyth M. A., Barrett T. 1995; Evaluation of polymerase chain reaction for the detection and characterization of rinderpest and peste des petits ruminants viruses for epidemiologic studies. Virus Res 39:151–163 [CrossRef]
     [Google Scholar]
  16. Fuerst T. R., Niles E. G., Studier F. W., Moss B. 1986; Eukaryotic transient-expression system based on recombinant vaccinia virus that synthesizes bacteriophage T7 RNA polymerase. Proc Natl Acad Sci U S A 83:8122–8126 [CrossRef]
     [Google Scholar]
  17. Garcin D., Itoh M., Kolakofsky D. 1997; A point mutation in the Sendai virus accessory C proteins attenuates virulence for mice, but not virus growth in cell culture. Virology 238:424–431 [CrossRef]
     [Google Scholar]
  18. Haller A. A., Miller T., Mitiku M., Coelingh K. 2000; Expression of the surface glycoproteins of human parainfluenza virus type 3 by bovine parainfluenza virus type 3, a novel attenuated virus vaccine vector. J Virol 74:11626–11635 [CrossRef]
     [Google Scholar]
  19. Hsu D., Yamanaka M., Miller J., Dale B., Grubman M., Yilma T. 1988; Cloning of the fusion gene of rinderpest virus: comparative sequence analysis with other morbilliviruses. Virology 166:149–153 [CrossRef]
     [Google Scholar]
  20. Ismail T., Ahmad S., D'Souza-Ault M., Bassiri M., Saliki J., Mebus C., Yilma T. 1994; Cloning and expression of the nucleocapsid gene of virulent Kabete-O strain of rinderpest virus in baculovirus: use in differential diagnosis between vaccinated and infected animals. Virology 198:138–147 [CrossRef]
     [Google Scholar]
  21. Itoh M., Isegawa Y., Hotta H., Homma M. 1997; Isolation of an avirulent mutant of Sendai virus with two amino acid mutations from a highly virulent field strain through adaptation to LLC-MK2 cells. J Gen Virol 78:3207–3215
     [Google Scholar]
  22. Juhasz K., Whitehead S. S., Bui P. T., Biggs J. M., Crowe J. E., Boulanger C. A., Collins P. L., Murphy B. R. 1997; The temperature-sensitive (ts) phenotype of a cold-passaged (cp) live attenuated respiratory syncytial virus vaccine candidate, designated cpts530, results from a single amino acid substitution in the L protein. J Virol 71:5814–5819
     [Google Scholar]
  23. Kato A., Kiyotani K., Sakai Y., Yoshida T., Nagai Y. 1997; The paramyxovirus, Sendai virus, V protein encodes a luxury function required for viral pathogenesis. EMBO J 16:578–587 [CrossRef]
     [Google Scholar]
  24. Kobune F., Sakata H., Sugiyama M., Sugiura A. 1991; B95a, a marmoset lymphoblastoid cell line, as a sensitive host for rinderpest virus. J Gen Virol 72:687–692 [CrossRef]
     [Google Scholar]
  25. Lawson N. D., Stillman E. A., Whitt M. A., Rose J. K. 1995; Recombinant vesicular stomatitis viruses from DNA. Proc Natl Acad Sci U S A 92:4477–4481 [CrossRef]
     [Google Scholar]
  26. Mariner J. C., Roeder P. L. 2003; Use of participatory epidemiology in studies of the persistence of lineage 2 rinderpest virus in East Africa. Vet Rec 152:641–647 [CrossRef]
     [Google Scholar]
  27. Mebatsion T., Verstegen S., De Vaan L. T. C., Romer-Oberdorfer A., Schrier C. C. 2001; A recombinant Newcastle disease virus with low-level V protein expression is immunogenic and lacks pathogenicity for chicken embryos. J Virol 75:420–428 [CrossRef]
     [Google Scholar]
  28. Mioulet V., Barrett T., Baron M. D. 2001; Scanning mutagenesis identifies critical residues in the rinderpest virus genome promoter. J Gen Virol 82:2905–2911
     [Google Scholar]
  29. Newman J. T., Riggs J. M., Surman S. R., McAuliffe J. M., Mulaikal T. A., Collins P. L., Murphy B. R., Skiadopoulos M. H. 2004; Generation of recombinant human parainfluenza virus type 1 vaccine candidates by importation of temperature-sensitive and attenuating mutations from heterologous paramyxoviruses. J Virol 78:2017–2028 [CrossRef]
     [Google Scholar]
  30. Novella I. S., Ball L. A., Wertz G. W. 2004; Fitness analyses of vesicular stomatitis strains with rearranged genomes reveal replicative disadvantages. J Virol 78:9837–9841 [CrossRef]
     [Google Scholar]
  31. Ohishi K., Inui K., Yamanouchi K., Barrett T. 1999; Cell-mediated immune responses in cattle vaccinated with a vaccinia virus recombinant expressing the nucleocapsid (N) protein of rinderpest virus. J Gen Virol 80:1627–1634
     [Google Scholar]
  32. Plowright W., Ferris R. D. 1962; Studies with rinderpest virus in tissue culture. The use of attenuated culture virus as a vaccine for cattle. Res Vet Sci 3:172–182
     [Google Scholar]
  33. Reed L. J., Muench H. 1938; A simple method of estimating fifty per cent endpoints. Am J Hyg 27:493–497
     [Google Scholar]
  34. Schmidt A. C., Wenzke D. R., McAuliffe J. M., St Claire M., Elkins W. R., Murphy B. R., Collins P. L. 2002; Mucosal immunization of rhesus monkeys against respiratory syncytial virus subgroups A and B and human parainfluenza virus type 3 by using a live cDNA-derived vaccine based on a host range-attenuated bovine parainfluenza virus type 3 vector backbone. J Virol 76:1089–1099 [CrossRef]
     [Google Scholar]
  35. Schnell M. J., Mebatsion T., Conzelmann K.-K. 1994; Infectious rabies virus from cloned cDNA. EMBO J 13:4195–4203
     [Google Scholar]
  36. Shaffer J. A., Bellini W. J., Rota P. A. 2003; The C protein of measles virus inhibits the type I interferon response. Virology 315:389–397 [CrossRef]
     [Google Scholar]
  37. Skiadopoulos M. H., Surman S. R., St Claire M., Elkins W. R., Collins P. L., Murphy B. R. 1999; Attenuation of the recombinant human parainfluenza virus type 3 cp45 candidate vaccine virus is augmented by importation of the respiratory syncytial virus cpts530 L polymerase mutation. Virology 260:125–135 [CrossRef]
     [Google Scholar]
  38. Spann K. M., Collins P. L., Teng M. N. 2003; Genetic recombination during coinfection of two mutants of human respiratory syncytial virus. J Virol 77:11201–11211 [CrossRef]
     [Google Scholar]
  39. Steinhauer D. A., Holland J. J. 1986; Direct method for quantitation of extreme polymerase error frequencies at selected single base sites in viral RNA. J Virol 57:219–228
     [Google Scholar]
  40. Sweetman D. A., Miskin J., Baron M. D. 2001; Rinderpest virus C and V proteins interact with the major (L) component of the viral polymerase. Virology 281:193–204 [CrossRef]
     [Google Scholar]
  41. Takeda M., Takeuchi K., Miyajima N., Kobune F., Ami Y., Nagata N., Suzaki Y., Nagai Y., Tashiro M. 2000; Recovery of pathogenic measles virus from cloned cDNA. J Virol 74:6643–6647 [CrossRef]
     [Google Scholar]
  42. Tao T., Skiadopoulos M. H., Davoodi F., Riggs J. M., Collins P. L., Murphy B. R. 2000; Replacement of the ectodomains of the hemagglutinin–neuraminidase and fusion glycoproteins of recombinant parainfluenza virus type 3 (PIV3) with their counterparts from PIV2 yields attenuated PIV2 vaccine candidates. J Virol 74:6448–6458 [CrossRef]
     [Google Scholar]
  43. Tober C., Seufert M., Schneider H., Billeter M. A., Johnston I. C., Niewiesk S., ter Meulen V., Schneider-Schaulies S. 1998; Expression of measles virus V protein is associated with pathogenicity and control of viral RNA synthesis. J Virol 72:8124–8132
     [Google Scholar]
  44. Ward C. D., Stokes M. A., Flanegan J. B. 1988; Direct measurement of the poliovirus RNA polymerase error frequency in vitro. J Virol 62:558–562
     [Google Scholar]
  45. Wertz G. W., Perepelitsa V. P., Ball L. A. 1998; Gene rearrangement attenuates expression and lethality of a nonsegmented negative strand RNA virus. Proc Natl Acad Sci U S A 95:3501–3506 [CrossRef]
     [Google Scholar]
  46. Whelan S. P. J., Ball L. A., Barr J. N., Wertz G. T. W. 1995; Efficient recovery of infectious vesicular stomatitis virus entirely from cDNA clones. Proc Natl Acad Sci U S A 92:8388–8392 [CrossRef]
     [Google Scholar]
  47. Whitehead S. S., Firestone C. Y., Collins P. L., Murphy B. R. 1998; A single nucleotide substitution in the transcription start signal of the M2 gene of respiratory syncytial virus vaccine candidate cpts248/404 is the major determinant of the temperature-sensitive and attenuation phenotypes. Virology 247:232–239 [CrossRef]
     [Google Scholar]
  48. Whitehead S. S., Bukreyev A., Teng M. N., Firestone C. Y., St Claire M., Elkins W. R., Collins P. L., Murphy B. R. 1999a; Recombinant respiratory syncytial virus bearing a deletion of either the NS2 or SH gene is attenuated in chimpanzees. J Virol 73:3438–3442
     [Google Scholar]
  49. Whitehead S. S., Firestone C. Y., Karron R. A., Crowe J. E. Jr, Elkins W. R., Collins P. L., Murphy B. R. 1999b; Addition of a missense mutation present in the L gene of respiratory syncytial virus (RSV) cpts530/1030 to RSV vaccine candidate cpts248/404 increases its attenuation and temperature sensitivity. J Virol 73:871–877
     [Google Scholar]
  50. Whitehead S. S., Hill M. G., Firestone C. Y., St Claire M., Elkins W. R., Murphy B. R., Collins P. L. 1999c; Replacement of the F and G proteins of respiratory syncytial virus (RSV) subgroup A with those of subgroup B generates chimeric live attenuated RSV subgroup B vaccine candidates. J Virol 73:9773–9780
     [Google Scholar]
  51. Yamanaka M., Hsu D., Crisp T., Dale B., Grubman M., Yilma T. 1988; Cloning and sequence analysis of the hemagglutinin gene of the virulent strain of rinderpest virus. Virology 166:251–253 [CrossRef]
     [Google Scholar]
  52. Yamanaka M., Dale B., Crisp T., Cordell B., Grubman M., Yilma T. 1992; Sequence analysis and editing of the phosphoprotein (P) gene of rinderpest virus. Virology 190:553–556 [CrossRef]
     [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jgv/10.1099/vir.0.80751-0
Loading
The Plowright vaccine strain of Rinderpest virus has attenuating mutations in most genes
J. Gen. Virol. 86, 1093 (2005); https://doi.org/10.1099/vir.0.80751-0
/content/journal/jgv/10.1099/vir.0.80751-0
/content/journal/jgv/10.1099/vir.0.80751-0
Loading

Data & Media loading...

Most cited Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error